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LCommentary on ‘‘Thoracic aortic endografting facilitates the
resection of tumors infiltrating the aorta’’
Marc R. Moon, MDSee related article by Collaud et al in the April 2014
issue (J Thorac Cardiovasc Surg. 2014;147:1178-82).Collaud and associates1 from Toronto have described their
experience with prophylactic stent-graft placement fol-
lowed by wide resection for lung cancer invading the
thoracic aorta.1 This clinical scenario is rare, only 5 patients
in 5 years at one of the larger thoracic surgical centers in the
world, but it can present a formidable surgical challenge
even in the most experienced of hands. The classic approach
for tumors that invade the mid descending aorta is to gain
proximal and distal control; if penetration deep to the adven-
titial layer is encountered, partial or complete circumferen-
tial resection is performed. Patch repair with bovine
pericardium, placement of a short Dacron polyester fabric
graft or end-to-end reanastomosis restores aortic integrity.
A clamp and sew approach is possible, but I prefer a brief
period of extracorporeal bypass to maintain distal perfusion.
There is a theoretic concern that the addition of cardiopul-
monary bypass might increase risk, potentially related to in-
flammatory changes and fluid shifts with increased bleeding
consequent to heparinization. In my experience, however,
most of these tumor resections can be performedwith partial
left heart bypasswith venous inflow through the nonresected
pulmonary vein or left atrial appendage and arterial return
through the distal aorta or femoral artery. Full hepariniza-
tion is not required with left heart bypass (activated clotting
times of 250 seconds are adequate), pump times are short
(30 minutes or less), and the priming volume is low with a
small circuit, eliminating the hemodilution that typically oc-
curs with full cardiopulmonary bypass. Of course, this
approach necessitates the inclusion of a thoracic aortic sur-
geon as part of the operative team, but when this is properly
performed, the patient ‘‘hardly notices’’ that the aorta has
been clamped. Remember, as Dr Norman Shumway used
to say, ‘‘The pump is your friend.’’2
Collaud and associates1 did not include any historical
controls, so it is difficult to assess the claim of a diminution
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1456 The Journal of Thoracic and Cardiovascular Surextended resection in 125 patients, including 14 with aortic
involvement. This 2013 series and an older 2008 series from
Europe reported 0% mortality, with major morbidity rates
of 7% to 23%.3,4 Prophylactic stent-graft placement fol-
lowed by aortic resection without the pump, as described
Collaud and associates,1 is not without theoretic risks. These
include an additional surgical procedure, coverage of amore
extensive length of aortic lumen (4-cm landing zone on each
end of the resection margin), and a small but real lifelong
risk of erosion or infection with a stent-graft in an otherwise
normal segment of aorta. Furthermore, I have nightmares at
the thought of an exposed endograft in an infected field, a
problem that may be less likely if primary reanastomosis
or a bovine patch reconstruction had been performed. That
being said, there are two clinical scenarios in which I feel
that the Toronto approach offers a potential advantage. First,
this technique appears quite beneficial when aortic arch
involvement is present. The principles of proximal and
distal control are difficult to follow with invasion of the
arch, and fenestrated stent-grafts, as recently described by
Nagata and associates,5 offer a potential powerful tool to
treat these patients. Second, for tumors that invade the spine,
the endograft will exclude intercostals in the region of resec-
tion to potentially decrease intraoperative bleeding during
resection of the involved vertebrae.
Technically speaking, Collaud and associates1 note that
in patient 5 the aortic defect was reconstructed over the
stent-graft with bovine pericardium to prevent the stent-
graft from protruding and bleeding at each end. I strongly
encourage them to repair the aortic defect with bovine peri-
cardium always, even if the defect is small, to exclude the
prosthetic graft from the pleural space and decrease the
risk of aortopulmonary or aortoesophageal fistulization. I
would not be content with a simple pleural or intercostal
muscle flap coverage in most of these cases.
In summary, the Toronto group has developed a tech-
nique that works well in their hands and is likely reproduc-
ible by those experienced in endovascular techniques and
complex thoracic surgery. This is an approach that tertiary
centers can now add to their surgical armamentarium. I
feel strongly however, that this should not be considered
the standard of care and that inexperienced surgeons should
not consider this a low-risk approach that allows them to
attack a very complex surgical problem with which they
would otherwise not be comfortable.References
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